共 50 条
- [41] EVALUATION OF A COMBINATION ANTIEMETIC REGIMEN INCLUDING LV HIGH-DOSE METOCLOPRAMIDE, DEXAMETHASONE, AND DIPHENHYDRAMINE IN CISPLATIN-BASED CHEMOTHERAPY REGIMENS [J]. CANCER TREATMENT REPORTS, 1985, 69 (7-8): : 909 - 910
- [42] INTRAVENOUS METOCLOPRAMIDE - AN EFFECTIVE ANTIEMETIC IN CANCER-CHEMOTHERAPY [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 247 (19): : 2683 - 2686
- [44] Olanzapine is an effective antiemetic agent [J]. ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (03) : 628 - 630
- [45] THE BENEFIT AND RISK OF HIGH-DOSE METOCLOPRAMIDE IN COMPARISON TO HIGH-DOSE HALOPERIDOL OR TRIFLUPROMAZINE IN CISPLATIN-INDUCED EMESIS [J]. KLINISCHE WOCHENSCHRIFT, 1985, 63 (09): : 428 - 432
- [46] PHARMACOKINETIC STUDIES OF HIGH-DOSE METOCLOPRAMIDE WITH AND WITHOUT FORCED DIURESIS [J]. KLINISCHE WOCHENSCHRIFT, 1985, 63 (12): : 572 - 574
- [47] HIGH-DOSE METOCLOPRAMIDE FOR CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1981, 38 (09): : 1282 - &
- [49] TARDIVE-DYSKINESIA ASSOCIATED WITH HIGH-DOSE INTRAVENOUS METOCLOPRAMIDE [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (08): : 518 - 518